ESR Projects
The 10 proEVLifeCycle ESR projects
ESR1
Manipulating EV uptake and production for therapeutic intervention of prostate cancer progression
Erasmus MC, Rotterdam, The Netherlands
Prof. dr. Guido Jenster (proEVLifeCycle coordinator) and Dr. Martin van Royen
ESR2
Characterizing EV sub-population manufacture/secretion by prostate cancer cells, to identify vesicle subpopulation(s) that are functionally relevant for disease propagation and relevant as biomarkers
Cardiff University, Cardiff, United Kingdom
Prof. dr. Aled Clayton and Dr. Jason Webber
ESR3
EV glycosylations as therapeutic and diagnostic targets of prostate cancer
University of Turku, Finland
Dr. Urpo Lamminmäki and Dr. Janne Leivo
ESR4
Exosome transport and uptake across biological barriers
AIT Austrian Institute of Technology, Vienna, Austria
Dr. Christa Noehammer and Dr. Winfried Neuhaus
ESR5
EVs as surrogated biomarkers of prostate cancer metabolism
CIC bioGUNE, Asociacion Centro de Investigacion Cooperative en Biociencias, Derio, Spain
Prof. dr. Juan M. Falcón-Perez
ESR6
Tracking endogenous prostate cancer-derived EVs in vivo
INSERM – Institute of Psychiatry and Neurosciences of Paris, France
Dr. Guillaume van Niel
ESR7
EV dissemination in the lymphatic system and pre-metastatic niche formation
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III, Madrid, Spain
Dr. Hector Peinado
ESR8
Coding and non-coding RNA in prostate cancer-derived EVs
GenomeScan B.V., Leiden, The Netherlands
Dr. Magda Grudniewska-Lawton
ESR9
Network-based computational methods for EV datasets analysis
Anaxomics Biotech, S.L., Barcelona, Spain
Dr. Judith Farrés & Dr. José Manuel Mas
ESR10
EVs as drug delivery system
University Medical Center Utrecht, Utrecht, The Netherlands
Prof. dr. Raymond Schiffelers
